Basics |
Organon & Co..
|
IPO Date: |
May 14, 2021 |
Sector: |
Healthcare |
Industry: |
Drug Manufacturers - General |
Market Cap: |
$2.7B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.36 | 1.64%
|
Avg Daily Range (30 D): |
$0.24 | 2.45%
|
Avg Daily Range (90 D): |
$0.24 | 2.46%
|
Institutional Daily Volume |
Avg Daily Volume: |
2.34M |
Avg Daily Volume (30 D): |
3.76M |
Avg Daily Volume (90 D): |
4.43M |
Trade Size |
Avg Trade Size (Sh.): |
99 |
Avg Trade Size (Sh.) (30 D): |
134 |
Avg Trade Size (Sh.) (90 D): |
140 |
Institutional Trades |
Total Inst.Trades: |
3,868 |
Avg Inst. Trade: |
$3.51M |
Avg Inst. Trade (30 D): |
$3.44M |
Avg Inst. Trade (90 D): |
$3.51M |
Avg Inst. Trade Volume: |
.17M |
Avg Inst. Trades (Per Day): |
3 |
Market Closing Trades |
Avg Closing Trade: |
$8.05M |
Avg Closing Trade (30 D): |
$4.83M |
Avg Closing Trade (90 D): |
$6.16M |
Avg Closing Volume: |
391.35K |
|
|
News |
Aug 14, 2025 @ 8:18 PM
Daré Bioscience Posts Narrower Q2 Loss
Source: Jesterai
|
Jul 23, 2025 @ 5:00 PM
Global Dysmenorrhea Treatment Market to Cross ~USD...
Source: Delveinsight
|
Jul 21, 2025 @ 8:00 PM
OGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman ...
Source: Bronstein, Gewirtz & Grossman Llc
|
Jul 21, 2025 @ 5:47 PM
UPDATE - Daré Bioscience to Host August 6 Webin...
Source: Daré Bioscience, Inc.
|
Jul 20, 2025 @ 2:55 PM
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LL...
Source: Faruqi & Faruqi, Llp
|
Financials |
|
TTM |
Q2 2025 |
Q1 2025 |
Basic EPS
|
$2.71
|
$.56
|
$.34
|
Diluted EPS
|
$2.68
|
$.56
|
$.33
|
Revenue
|
$ 6.28B
|
$ 1.59B
|
$ 1.51B
|
Gross Profit
|
$ 3.53B
|
$ 874M
|
$ 841M
|
Net Income / Loss
|
$ 700M
|
$ 145M
|
$ 87M
|
Operating Income / Loss
|
$ 666M
|
$ 229M
|
$ 101M
|
Cost of Revenue
|
$ 2.75B
|
$ 720M
|
$ 672M
|
Net Cash Flow
|
$ -105M
|
$ 52M
|
$ -128M
|
PE Ratio
|
3.90
|
|
|
|
|
|